Molecular Tests May Change Cancer Screening
As the accuracy of traditional cancer screening is called into question, molecular and genetic tests promise an alternative, noninvasive form of early detection.
cancer
Treating Rare Diseases at Birth and Before: Dr. Phil Reilly
In his latest book, clinical geneticist and biotech entrepreneur Dr. Phil Reilly chronicles centuries of medical progress that have contributed to recent breakthroughs in rare disease medicines, diagnostics, and clinical care. He says we're just...
Molecular Signatures Are Redefining Cancer Treatment
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
Plastics: “The New Coal”
Plastics have yielded life-saving medical advances, supercharged technological advancements, helped send us to space, and transformed our lives in innumerable ways. But they are poisoning our people and our planet.
Most Genome Data Comes from White Folks. Scientists Are Trying to Fix That.
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
A Promising Vaccine Candidate for the Immunocompromised
Millions of people with weakened immune systems are poorly protected against Covid by current vaccines. Scientists in Germany have developed a new vaccine intended especially for them.
A Breakthrough Cancer Therapy Targets Autoimmune Diseases
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
Why the Chemical Industry Is an Overlooked Climate Foe — and What to Do About It
It’s time to overhaul the chemical industry — for the sake of fenceline communities and the rest of the planet.
Blood Test Shows Promise for Detecting Cancer Far Earlier
Scientists in Ontario used machine learning techniques to find telltale signs of cancer in blood samples that were collected up to seven years prior to conventional diagnosis.
